日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Inhibition of IGF-1Rα affects the differentiation fate of rat optic cup-derived retinal stem cells to retinal ganglion cells in vitro

体外实验表明,抑制IGF-1Rα会影响大鼠视杯来源的视网膜干细胞向视网膜神经节细胞的分化命运。

Qi-You Li ,Xiao-Ling Tan ,Hai-Wei Xu ,Yu-Xiao Zeng ,Xiao-Yong Huang

Translocation of IGF-1R in endoplasmic reticulum enhances SERCA2 activity to trigger Ca2+ER perturbation in hepatocellular carcinoma

IGF-1R在内质网中的易位增强了SERCA2的活性,从而引发肝细胞癌中Ca2+内质网的紊乱。

Yanan Li ,Keqin Li ,Ting Pan ,Qiaobo Xie ,Yuyao Cheng ,Xinfeng Wu ,Rui Xu ,Xiaohui Liu ,Li Liu ,Jiangming Gao ,Wenmin Yuan ,Xianjun Qu ,Shuxiang Cui

Pharmacological Inhibition of Insulin Growth Factor-1 Receptor (IGF-1R) Alone or in Combination With Ruxolitinib Shows Therapeutic Efficacy in Preclinical Myeloproliferative Neoplasm Models

单独或与鲁索替尼联合使用胰岛素样生长因子-1受体(IGF-1R)的药理学抑制在临床前骨髓增生性肿瘤模型中显示出治疗效果

Titiksha Basu ,Hannah Bertrand ,Nikolaos Karantzelis ,Albert Gründer ,Heike L Pahl

Transient IGF-1R inhibition combined with osimertinib eradicates AXL-low expressing EGFR mutated lung cancer

短暂性IGF-1R抑制联合奥希替尼可根除AXL低表达的EGFR突变型肺癌

Rong Wang ,Tadaaki Yamada ,Kenji Kita ,Hirokazu Taniguchi ,Sachiko Arai ,Koji Fukuda ,Minoru Terashima ,Akihiko Ishimura ,Akihiro Nishiyama ,Azusa Tanimoto ,Shinji Takeuchi ,Koshiro Ohtsubo ,Kaname Yamashita ,Tomoyoshi Yamano ,Akihiro Yoshimura ,Koichi Takayama ,Kyoichi Kaira ,Yoshihiko Taniguchi ,Shinji Atagi ,Hisanori Uehara ,Rikinari Hanayama ,Isao Matsumoto ,Xujun Han ,Kunio Matsumoto ,Wei Wang ,Takeshi Suzuki ,Seiji Yano

Development and preclinical evaluation of cixutumumab drug conjugates in a model of insulin growth factor receptor I (IGF-1R) positive cancer

在胰岛素样生长因子受体 I (IGF-1R) 阳性癌症模型中,西妥昔单抗药物偶联物的开发和临床前评估

Viswas Raja Solomon ,Elahe Alizadeh ,Wendy Bernhard ,Amal Makhlouf ,Siddesh V Hartimath ,Wayne Hill ,Ayman El-Sayed ,Kris Barreto ,Clarence Ronald Geyer ,Humphrey Fonge

Preclinical and phase I clinical studies of KW-2450, a dual IGF-1R/IR tyrosine kinase inhibitor, in combination with lapatinib and letrozole

KW-2450(一种双重IGF-1R/IR酪氨酸激酶抑制剂)联合拉帕替尼和来曲唑的临床前和I期临床研究

Hiroshi Umehara ,Yoshimi Maekawa ,Fumito Koizumi ,Makiko Shimizu ,Toshio Ota ,Tamer M Fouad ,Jie Willey ,Hidekuni Kaito ,Norihiko Shiraishi ,Daisuke Nakashima ,Shiro Akinaga ,Naoto T Ueno